Infant Vaccinations and Childhood Leukaemia Risk
Author Information
Author(s): Groves F D, Gridley G, Wacholder S, Shu X O, Robison L L, Neglia J P, Linet M S
Primary Institution: Division of Cancer Epidemiology and Genetics, National Cancer Institute
Hypothesis
Do infant vaccinations reduce the risk of childhood acute lymphoblastic leukaemia?
Conclusion
The study suggests that infants receiving the conjugate Hib vaccine may be at reduced risk of childhood acute lymphoblastic leukaemia.
Supporting Evidence
- The study compared vaccination histories of children with leukaemia to matched controls.
- Similar proportions of cases and controls received most vaccines.
- Only 47% of cases and 53% of controls received any Hib vaccine.
- More controls received the conjugate Hib vaccine compared to cases.
Takeaway
The study looked at whether getting vaccinated as a baby helps prevent a type of blood cancer in kids, and it found that one specific vaccine might help.
Methodology
Vaccination histories were compared in children diagnosed with acute lymphoblastic leukaemia and matched controls.
Limitations
Further studies are needed to confirm the association and understand the underlying mechanism.
Participant Demographics
Children aged 0–14 diagnosed with acute lymphoblastic leukaemia and matched controls.
Statistical Information
Confidence Interval
95% CI 0.50–1.06 for Hib vaccine; 95% CI 0.36–0.89 for conjugate Hib vaccine.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website